Activity-dependent secretion of brain-derived neurotrophic factor (BDNF) is thought to enhance synaptic plasticity, but the mechanisms controlling extracellular availability and clearance of secreted BDNF are poorly understood. We show that BDNF is secreted in its precursor form (pro-BDNF) and is then cleared from the extracellular space through rapid uptake by nearby astrocytes after θ-burst stimulation in layer II/III of cortical slices, a paradigm resulting in long-term potentiation of synaptic transmission. Internalization of pro-BDNF occurs via the formation of a complex with the pan-neurotrophin receptor p75 and subsequent clathrin-dependent endocytosis. Fluorescence-tagged pro-BDNF and real-time total internal reflection fluorescence microscopy in cultured astrocytes is used to monitor single endocytic vesicles in response to the neurotransmitter glutamate. We find that endocytosed pro-BDNF is routed into a fast recycling pathway for subsequent soluble NSF attachment protein receptor–dependent secretion. Thus, astrocytes contain an endocytic compartment competent for pro-BDNF recycling, suggesting a specialized form of bidirectional communication between neurons and glia.


Activity-dependent secretion of brain-derived neurotrophic factor (BDNF) into the extracellular space is a key step in the induction of long-term synaptic modification (Poo, 2001). It has been suggested that the effect of BDNF is critically dependent on whether it is secreted in its precursor form (pro-BDNF), which preferentially binds to the pan-neurotrophin receptor p75 (p75NTR), or in its mature form, which activates the tropomyosin-related kinase B receptor (TrkB), because activation of these distinct receptors has opposite effects on synaptic strength (Lu, 2005). In addition, pro-BDNF can be processed in the extracellular space by tissue plasminogen activator/plasmin (Pang et al., 2004), further modulating synaptic modification by the neurotrophin. However, it was recently reported that processing of pro-BDNF occurs intracellularly in cultured hippocampal neurons and that the neurotrophin is secreted only in its mature form (Matsumoto et al., 2008).

To improve our understanding of the mechanisms controlling the extracellular availability of endogenous BDNF and the termination of its action, we examined the fate of both pro-BDNF and mature BDNF in cortical brain slices after θ-burst stimulation (TBS), a well-established paradigm inducing both long-term potentiation of synaptic transmission and secretion of BDNF (Aicardi et al., 2004). We provide compelling evidence that BDNF, which is newly synthesized in neurons after TBS, is secreted in its pro-form and is then rapidly internalized in perineuronal astrocytes, thereby restricting the availability of the neurotrophin at neuron–astrocyte contacts. After internalization, the neurotrophin can undergo a recycling process, endowing astrocytes with the ability to resecrete the neurotrophin upon stimulation.

Results And Discussion

Field recordings were performed in layers II/III of rat perirhinal cortex slices (Fig. 1 A) subjected to either basal (0.033 Hz) or TBS (100 Hz) stimulation. BDNF secretion was measured in the collected perfusion medium by ELISA (Fig. 1 C). Although BDNF levels remained constant during basal stimulation, TBS induced a rapid, transient increase in BDNF in the perfusate, which correlated with induction of synaptic potentiation of the field potential as described previously (Aicardi et al., 2004). Fig. 1 C shows representative examples of pro-BDNF immunoreactivity in the perirhinal cortex upon basal and TBS stimulation using an antibody directed specifically (Fig. 1 B) against the pro-region of the neurotrophin. Basal levels of pro-BDNF were detected proximal to (Fig. 1 A, A1) and distal from (Fig. 1 A, A2) the stimulation electrode in controls. A marked increase in pro-BDNF immunoreactivity was observed after TBS, which gradually declined distally from the stimulation electrode. This effect was blocked by prior treatment with the protein synthesis inhibitor anisomycin (unpublished data), consistent with the pro-BDNF increase depending on activity-dependent local protein synthesis (Kandel, 2001). Similar results were obtained using an antibody directed against the mature portion of the neurotrophin that recognizes both mature and pro-BDNF (Fig. 1 D).

High resolution confocal analysis of individual neurons in the A1 region confirmed that pro-BDNF immunoreactivity was increased after TBS (Fig. 1 E and Fig. S1). Surprisingly, pro-BDNF was also localized in perineuronal astrocytes (Fig. 1 E). As astrocytes lack mRNA for BDNF (Ernfors et al., 1990; Conner et al., 1997), these data suggest that pro-BDNF was taken up by these cells upon secretion from nearby activated neurons. Notably, pro-BDNF immunoreactivity was typically punctate within astrocytic processes in contact with nearby neurons, whereas it appeared to be concentrated in larger clusters in the cell body (Fig. 1 E). This immunoreactivity pattern suggests intracellular trafficking of pro-BDNF after its transfer from nearby neurons to astrocytes at sites of neuron–glia contacts. We thus decided to follow the time course of pro-BDNF distribution within astrocytes after TBS (Fig. 1 F). Pro-BDNF uptake in individual astrocytes was determined by measuring colocalization of pro-BDNF immunoreactivity with that of the glial fibrillary acidic protein (GFAP), an astrocytic-specific cytoskeletal protein. In accordance with a transfer of pro-BDNF from neurons to astrocytes, colocalization of pro-BDNF to GFAP was first found within the periphery of astrocytic processes 5 min after TBS. At later time points (10–30 min), the overall quantity of pro-BDNF found in astrocytes had increased, and the intracellular distribution gradually shifted from the processes to the cell body. Finally, pro-BDNF levels returned to basal levels in both compartments after 3 h.

Although astrocytes were largely devoid of pro-BDNF under basal stimulation, 10–12% of GFAP-labeled individual astrocytes were positive for pro-BDNF 10 min after TBS (Fig. 1 G and Fig. S1). This effect was prevented by prior incubation with anisomycin, indicating that accumulation of pro-BDNF in astrocytes required activity-dependent synthesis in neurons, or with TrkB-Fc, a scavenger for secreted BDNF in both precursor and mature forms (Fayard et al., 2005). Strikingly, the astrocytic uptake was selective for pro-BDNF, as it was markedly reduced upon prior incubation with plasmin (Fig. 1 G and Fig. S1), an enzyme responsible for the extracellular proteolysis of pro-BDNF to mature protein.

The fact that we observe pro-BDNF secretion stands in contrast to a recent study that BDNF may only be released in its processed, mature form (Matsumoto et al., 2008). This discrepancy may be due to the fact that, in the latter study, BDNF processing was studied in unstimulated hippocampal tissue and hippocampal cultures after prolonged (1 d) stimulation, whereas we obtained evidence for transient pro-BDNF secretion within a few minutes after TBS. Much of this secreted pro-BDNF has been newly synthesized and, given the rapid transfer to astrocytes, is likely to derive from locally translated BDNF mRNA. Interestingly, another recent study has shown that BDNF mRNA occurs in two splice variants, one of which is selectively transported to the dendrites of hippocampal neurons, and BDNF derived from this transcript is required for synaptic and morphological modifications (An et al., 2008). Local synthesis may indeed favor secretion of pro-BDNF given that the machinery to process the neurotrophin is likely to be absent from dendrites.

We next investigated whether pro-BDNF uptake by astrocytes occurs by receptor-mediated internalization. We observed that pro-BDNF immunoreactivity within astrocytes colocalized with that of p75NTR 10 min after TBS. Clusters of pro-BDNF–p75NTR were found at sites in contact with nearby neurons and astrocytic processes, a pattern suggestive of p75NTR-mediated internalization of pro-BDNF (Fig. 2 A). Accordingly, in slices of p75NTR knockout mice (p75NTR−/−; Naumann et al., 2002) and different from slices of wild-type mice (p75NTR+/+), pro-BDNF did not accumulate in astrocytes (Fig. 2 B and Fig. S2). However, preventing TrkB internalization with the kinase inhibitor K252a did not affect GFAP/pro-BDNF colocalization (Fig. 2 C), which is consistent with the notion that astrocytes do not express the full-length form of TrkB (Rose et al., 2003). Because data obtained in slices do not rule out the involvement in BDNF endocytosis of truncated TrkB (TrkB-t) forms (Rubio, 1997) lacking the catalytic domains (Klein et al., 1990), experiments were extended to primary cultures of cortical astrocytes. Surface biotinylation experiments showed that, in addition to p75NTR, cultured astrocytes express TrkB-t but not full-length TrkB (Fig. 2 D). However, upon exposure of astrocytes to BDNF, a mixture of precursor and mature isoforms (mix; Fig. 1 B), only the membrane expression of p75NTR, but not TrkB-t, was reduced. As a consequence, the same lysate in which plasma membrane levels of p75NTR were reduced by BDNF (mix) contained a high quantity of BDNF protein. Altogether, these data indicate that pro-BDNF uptake occurs primarily by p75NTR, which is consistent with the notion that pro-BDNF binds preferentially to this receptor (Teng et al., 2005).

To further investigate the molecular mechanism of pro-BDNF–p75NTR-mediated internalization, we examined whether endocytic pro-BDNF colocalized with clathrin (Bronfman et al., 2003). We found that clathrin immunoreactivity colocalized with that of pro-BDNF after TBS (Fig. 2 A). This effect was blocked by prior treatment with the clathrin inhibitor monodansylcadaverine (MDC) or the dynamin blocker D15 (Fig. 2 C and Fig. S2; Wigge and McMahon, 1998). Likewise, we observed colocalization of pro-BDNF with the early endosomal marker EEA1 (Fig. 2 A). Overall, these data provide evidence that astrocytic uptake of endogenous pro-BDNF occurs via p75NTR–clathrin-mediated internalization in endocytic compartments.

To obtain further insight into the possible regulation of pro-BDNF uptake in astrocytes, total internal reflection fluorescence (TIRF) microscopy (Thompson and Steele, 2007) was used to visualize the formation of single endocytic vesicles in real time (Fig. 3 A and Video 1). Cultured astrocytes were transfected with p75NTR tagged with GFP (p75-GFP) for evanescent light excitation of p75-GFP residing within or in close proximity to the plasma membrane. The binding of pro-BDNF to p75-GFP was imaged in real time using pro-BDNF immunocomplexed with 10 nM of quantum dots (QDs; Fig. S3). Once a pro-BDNF–QD was found in the vicinity of the plasma membrane of a p75-GFP–expressing astrocyte, p75-GFP fluorescence became concentrated at the site of the QD within a few seconds, presumably reflecting the formation of endocytic vesicles and internalization of the pro-BDNF–QDs. Confocal microscopy (Fig. 3 B) showed that internalization of pro-BDNF–QDs was inhibited at a nonpermissive temperature (ice cold) for endocytosis and was restored by raising the temperature to 37°C for 10–20 min. QD uptake also depended on the level of p75NTR expression: although astrocytes overexpressing p75-GFP showed high levels of QD internalization, significantly fewer QDs were taken up in astrocytes transfected with plasma membrane–linked GFP (Lck-GFP), which only relies on endogenous p75NTR for internalization (Fig. 3, B and D). Likewise, QD uptake was virtually abolished in astrocytes prepared from p75NTR−/− mice (Fig. 3 C). Moreover, QD internalization required prior coupling to pro-BDNF, as it ceased when the α–pro-BDNF antibody was omitted from the immunocomplexes for control (Fig. 3 B). Lastly, internalized QDs colocalized with clathrin and EEA1 (Fig. S3), confirming in primary cultures the mechanism of pro-BDNF endocytosis shown in stimulated slices.

What is the fate of internalized pro-BDNF? The sorting of endocytic vesicles has been suggested to lead to either vesicle recycling or vesicle entering the degradation pathway (Maxfield and McGraw, 2004; Soldati and Schliwa, 2006). This prompted us to investigate whether internalized pro-BDNF can eventually be recycled for regulated secretion. To this end, cultures were incubated for 10 min with a mixture of both precursor and mature BDNF tagged with YFP (BDNF-YFP mix; Fig. 4 A). Internalized BDNF-YFP showed a punctate pattern concentrated at the cell periphery of cultured astrocytes (Fig. 4 B). Ultrastructural characterization by preembedding experiments using immunogold-labeled BDNF-YFP (BDNF-YFP gold; Fig. S3) disclosed gold particles within vesicular structures (mean diameter, 125 ± 22 nm; n = 32; Fig. 4 C). Whether vesicles containing internalized BDNF-YFP are eventually destined for recycling was next evaluated by exploiting the pH sensitivity of BDNF-YFP. YFP fluorescence quenching inside acidic compartments followed by its unquenching upon BDNF-YFP secretion into the extracellular medium revealed fluorescent flashes by TIRF imaging (Santi et al., 2006). After loading astrocytes by brief exposure (1–5 min) to BDNF-YFP (mix), fluorescent vesicles appeared near the plasma membrane (Fig. 4 D and Video 2). Challenging astrocytes with glutamate triggered flashes lasting several hundred milliseconds. Only when fluorescence increased, spread, and subsequently declined was the flash considered an exocytic event. Quantitative analysis demonstrated that glutamate induced about a 10-fold increase in exocytic events (73 ± 12 mean flashes/astrocyte ± SD; n = 18) with respect to the control bath solution (6 ± 3 mean flashes/astrocyte ± SD; n = 6; Fig. 4 E). Most of the fusion events took place during the first 10 s of glutamate application. Because recycling is visualized by TIRF rapidly after exogenous BDNF-YFP administration, it is likely that endocytic vesicles containing BDNF-YFP can enter the exocytic process directly. Thus, endocytic vesicles may represent the main storage compartment for endocytosed BDNF-YFP before routing to the secretory pathway.

Lastly, neurotrophin recycling was determined by ELISA measurement of BDNF in supernatants collected from cultured astrocytes or astrocytes exposed to BDNF (mix) for 10 min and thoroughly washed (Fig. 4 F). Although challenge with glutamate for 5 min did not result in endogenous BDNF secretion from control cells, the same stimulation increased the neurotrophin secretion in BDNF preincubated cells. Neurotrophin release was strongly reduced by overnight intoxication with 40 nM tetanus neurotoxin (TeNT), a protease known to cleave the SNARE protein vesicle-associated membrane protein 2 (Vamp2)/synaptobrevin2 (Montana et al., 2006) and implicated in the regulated release of neurotransmitters from astrocytes (Bezzi et al., 2004). The effect of glutamate was mimicked by 50 μM AMPA or 100 μM t-ACPD, which activate AMPA or metabotropic group I/II glutamate receptors, respectively (Fig. 4 G). BDNF secretion induced by AMPA or t-ACPD was heavily reduced by the AMPA antagonists CNQX or by the metabotropic group I receptor antagonist AIDA. High frequency (50 Hz) electrical stimulation, which is known to trigger secretion of BDNF in cultured neurons (Balkowiec and Katz, 2000), was not effective (Fig. 4 G), indicating that BDNF secretion from astrocytes cannot be directly regulated by activity.

How is the endocytic pro-BDNF recycled for exocytosis? One potential mechanism making endocytic vesicles available for secretion involves the molecular machinery deputed to exocytic fusion. Astrocytes are known to express components of the core SNARE complex, including Vamp2 (Montana et al., 2006). Colocalization of pro-BDNF with Vamp2 was detected within astrocytes in slices 10 min after TBS (Fig. 5 A) or in cultured astrocytes transfected with p75-GFP and exposed to pro-BDNF–QDs (Fig. 5 B). The expression of Vamp2 on BDNF-containing vesicles was confirmed by Western blot analysis of endocytic vesicles purified by magnetic beads coated with α-p75NTR antibodies (Fig. 5 C). Conversely, endocytic vesicles purified using beads coated with α-Vamp2 antibodies were immunoreactive for p75NTR. Interestingly, treatment with BDNF (mix) for 10 min enhanced the recovery of vesicles expressing both Vamp2 and p75NTR. Beads coated with antibodies against the neuronal marker microtubule-associated protein 2 (Map2) were used as a control. These data indicate that endocytic vesicles expressing p75NTR may represent the main storage compartment for endocytosed pro-BDNF before routing to the secretory pathway. This process might take place either by recycling of pro-BDNF–p75NTR complexes to the surface or by pro-BDNF recycling upon its dissociation from p75NTR. Moreover, given that TeNT prevented BDNF secretion (Fig. 4 F), all of these data indicate that after endocytosis in astrocytes, vesicles containing the neurotrophin may undergo regulated recycling via a SNARE-dependent mechanism.

Our overall findings indicate that astrocytes exert an important function in the neuronal clearance of pro-BDNF secreted upon neuronal activity and subsequent recycling of the endocytic neurotrophin, thus regulating both its spatial and temporal availability. In this respect, astrocyte-mediated clearing and recycling of BDNF share some similarities with the astrocyte clearance of neurotransmitters from the synaptic cleft. Recycling of BDNF by these cells may thus contribute to the regulation of synaptic plasticity by glia (Haydon, 2001; Fields and Stevens-Graham, 2002; Allen and Barres, 2005; Haydon and Carmignoto, 2006).

Materials And Methods


Slice preparation and recordings were performed as previously reported (Aicardi et al., 2004). Slices were preincubated with 50 μM anisomycin, 1 μg/ml TrkB-Fc (Regeneron Pharmaceuticals, Inc.), 200 nM K252a, 50 μM MDC, and 20 μM D15 for 20 min or 100 nM plasmin for 2 h and were maintained throughout the recording by a recirculation system.

Immunohistochemistry and immunocytochemistry

Samples were subjected to conventional experimental procedures using chicken α–pro-BDNF (Millipore), chicken α-BDNF (Promega), rabbit or mouse α-GFAP (Sigma-Aldrich), mouse α–neuronal nuclei (Millipore), goat α-p75NTR (R&D Systems), rabbit α-EEA1 (Abcam), rabbit α-clathrin (Abcam), mouse α-Vamp2 (Synaptic Systems), and mouse (Invitrogen) or chicken α-GFP (Aves Laboratory) primary antibodies. Immunoreactivity was evaluated using a confocal laser-scanning microscope (Radiance 2000; Bio-Rad Laboratories) equipped with krypton–argon and red diode lasers and 20×/0.75, 60×/1.40, and 100×/1.40 oil objectives (Nikon). Image processing and volume rendering were performed using the ImageSpace software (Molecular Dynamics) running on an Indigo Workstation (Silicon Graphics).

Biotinylation assay

Cell surface biotinylation of intact astrocytes was performed as previously described (Santi et al., 2006).

Western blotting

Samples were subjected to a conventional experimental procedure using chicken α-BDNF (R&D Systems), rabbit and chicken α–pro-BDNF (Millipore), mouse α-TrkB (BD Biosciences), rabbit α-p75NTR (Abcam), mouse α-Vamp2 (Synaptic Systems), and mouse α-Map2 (a gift from A. Matus, Friedrich Miescher Institut, Basel, Switzerland) primary antibodies.

Cell cultures

Primary cultures of cortical astrocytes were prepared from postnatal day 1–2 Wistar rats and p75NTR+/+ or p75NTR−/− mice (provided by Y.-A. Barde, Biozentrum, University of Basel, Basel, Switzerland) as previously described (McCarthy and de Vellis, 1980).

Characterization of BDNF immunocomplexes


QD-565 surfaces immobilized with α-rabbit antibodies (Invitrogen) were used to passively bind rabbit α–pro-BDNF (Millipore). According to the manufacturer, single QD-565 shows the potential to be bioconjugated to <10 antibody molecules; thus, the desired degree of immunocoupling was set by adjusting the mixing stoichiometry between QDs and α–pro-BDNF to a 1:10 concentration. Incubation was performed for 10 min in a neutral buffer at 37°C. The final immunocomplex was obtained in a second step by incubating the QD/α–pro-BDNF mixture with 100 ng/ml BDNF (mix), which we show (Fig. 1 B) to contain BDNF in both precursor and mature forms. The correct formation of the pro-BDNF–QD immunocomplex was confirmed by immunocytochemistry (Fig. S3). The intensity profile of pro-BDNF–QD fluorescence was determined (Fig. S3) and compared with individual QDs as a reference. Although individual pro-BDNF–QDs showed high fluorescent fluctuation (blinking), pro-BDNF–QD clusters produced a larger variation in brightness but lower blinking. Confocal imaging revealed that 10 nM pro-BDNF–QDs were sufficient to visualize individual dots internalized into cultured astrocytes transfected with p75-GFP or Lck-GFP (provided by H. Lickert, Helmholtz Zentrum Muenchen, Neuherberg, Germany; Fig. 3 B). Higher concentrations (20–500 nM) increased QD clustering at the cell interspace and QDs decorated the surface of the cells, but internalization was strongly impaired.

BDNF-YFP gold.

The immunocomplex was prepared by two-step coupling procedures in which BDNF-YFP (mix; provided by O. Griesbeck, Max Planck Institute of Neurobiology, Martinsried, Germany) was first coupled with α-GFP for 10 min and, with a secondary antibody, coupled with 5-nm gold particles.

Electron microscopy

In preembedding experiments, cultured astrocytes were treated with BDNF-YFP gold for 10 min, fixed in 2.5% glutaraldehyde (0.1 M phosphate buffer) for 30 min at 4°C, and postfixed in 1% OsO4 for 60 min at room temperature. After dehydration, samples were embedded in epon 812 and counterstained with uranyl acetate–lead citrate. Sections were examined with an electron microscope (EM 109; Carl Zeiss, Inc.). The images were captured with a charge-coupled device camera (DMX 1200F; Nikon). Digital images were collected and analyzed using Image Pro+ software (Media Cybernetics, Inc.). Analysis was performed on at least 200 micrographs disclosing intracellular structures containing gold particles. The vesicle diameters were measured referring to calibrated latex beads.

Time-lapse TIRF imaging

TIRF imaging experiments were performed as described previously (Santi et al., 2006).

Characteristics of the perfusion setup and release experiments

Release experiments were performed as described previously (Canossa et al., 1997). Stimulations were obtained by adding 50 and 500 μM glutamate, 50 μM AMPA, and 100 μM t-ACPD over a 5-min period. Treatment with specific receptor antagonists (50 μM CNQX and 500 μM AIDA) started 30 min before the beginning of the perfusion and was maintained throughout the collection period. Intoxication with TeNT started 12 h before the beginning of perfusion and was not maintained throughout the collection period. High frequency stimulation was performed as reported previously (Santi et al., 2006). The amount of BDNF in each fraction was determined by a two-site ELISA (Canossa et al., 1997).

Vesicle immunopurification

Purifications were performed as previously described (Santi et al., 2006). Vesicles were immunoisolated from the postnuclear supernatant with α-mouse Dynabeads (M-280) coated with mouse α-p75NTR (Sigma-Aldrich), mouse α-Vamp2 (Synaptic Systems), or mouse α-Map2 (a gift from A. Matus) antibodies according to the manufacturer's instructions.

Online supplemental material

Figs. S1 and S2 show pro-BDNF internalization in individual astrocytes from control or TBS slices in the absence or presence of anisomycin, TrkB-Fc, plasmin and MDC, or in p75NTR+/+ and p75NTR−/− mice. Fig. S3 shows (a) a schematic representation of pro-BDNF–QD and BDNF-YFP gold immunocomplexes and (b) colocalization between pro-BDNF–QDs and clathrin or EEA1 in cultured astrocytes expressing p75-GFP. Video 1 shows real-time visualization of pro-BDNF–QD endocytosis in cultured astrocytes expressing p75-GFP obtained by TIRF imaging. Video 2 shows the exocytic fusion of BDNF-YFP–containing vesicles analyzed by TIRF microscopy.

© 2008 Bergami et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at

M. Bergami and S. Santi contributed equally to this paper.

Abbreviations used in this paper: BDNF, brain-derived neurotrophic factor; GFAP, glial fibrillary acidic protein; Map2, microtubule-associated protein 2; MDC, monodansylcadaverine; QD, quantum dot; TBS, θ-burst stimulation; TeNT, tetanus neurotoxin; TIRF, total internal reflection fluorescence; TrkB, tropomyosin-related kinase B receptor; TrkB-t, truncated TrkB; Vamp2, vesicle-associated membrane protein 2.


We thank H. Thoenen and M. Schliwa for comments on the manuscript.

This work was supported by the Ministero dell'Università e della Ricerca Programmi di Ricerca di Rilevante Interesse Nazionale, Ricerca Fondamentale Orientata (grant to M. Canossa), European Union Synapse (grant to M. Matteoli), and Deutsche Forschungsgemeinschaft (grant to R. Blum).


Aicardi, G., E. Argilli, S. Cappello, S. Santi, M. Riccio, H. Thoenen, and M. Canossa.
. Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor.
Proc. Natl. Acad. Sci. USA.
Allen, N.J., and B.A. Barres.
. Signaling between glia and neurons: focus on synaptic plasticity.
Curr. Opin. Neurobiol.
An, J.J., K. Gharami, G.Y. Liao, N.H. Woo, A.G. Lau, F. Vanevski, E.R. Torre, K.R. Jones, Y. Feng, B. Lu, and B. Xu.
. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.
Balkowiec, A., and D.M. Katz.
. Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ.
J. Neurosci.
Bezzi, P., V. Gundersen, J.L. Galbete, G. Seifert, C. Steinhauser, E. Pilati, and A. Volterra.
. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate.
Nat. Neurosci.
Bronfman, F.C., M. Tcherpakov, T.M. Jovin, and M. Fainzilber.
. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome.
J. Neurosci.
Canossa, M., O. Griesbeck, B. Berninger, G. Campana, R. Kolbeck, and H. Thoenen.
. Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity.
Proc. Natl. Acad. Sci. USA.
Conner, J.M., J.C. Lauterborn, Q. Yan, C.M. Gall, and S. Varon.
. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport.
J. Neurosci.
Ernfors, P., C. Wetmore, L. Olson, and H. Persson.
. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family.
Fayard, B., S. Loeffler, J. Weis, E. Vögelin, and A. Krüttgen.
. The secreted brain-derived neurotrophic factor precursor proBDNF binds to TrkB and p75NTR but not to TrkA or TrkC.
J. Neurosci. Res.
Fields, R.D., and B. Stevens-Graham.
. New insights into neuron-glia communication.
Haydon, P.G.
. GLIA: listening and talking to the synapse.
Nat. Rev. Neurosci.
Haydon, P.G., and G. Carmignoto.
. Astrocyte control of synaptic transmission and neurovascular coupling.
Physiol. Rev.
Kandel, E.R.
. The molecular biology of memory storage: a dialogue between genes and synapses.
Klein, R., D. Conway, L.F. Parada, and M. Barbacid.
. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain.
Lu, B.
. The yin and yang of neurotrophin action.
Nat. Rev. Neurosci.
Matsumoto, T., S. Rauskolb, M. Polack, J. Klose, R. Kolbeck, M. Korte, and Y.A. Barde.
. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not proBDNF.
Nat. Neurosci.
Maxfield, F.R., and T.E. McGraw.
. Endocytic recycling.
Nat. Rev. Mol. Cell Biol.
McCarthy, K.D., and J. de Vellis.
. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
J. Cell Biol.
Montana, V., E.B. Malarkey, C. Verderio, M. Matteoli, and V. Parpura.
. Vesicular transmitter release from astrocytes.
Mowla, S.J., H.F. Farhadi, S. Pareek, J.K. Atwal, S.J. Morris, N.G. Seidah, and R.A. Murphy.
. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor.
J. Biol. Chem.
Naumann, T., E. Casademunt, E. Hollerbach, J. Hofmann, G. Dechant, M. Frotscher, and Y.A. Barde.
. Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons.
J. Neurosci.
Pang, P.T., H.K. Teng, E. Zaitsev, N.T. Woo, K. Sakata, S. Zhen, K.K. Teng, W.H. Yung, B.L. Hempstead, and B. Lu.
. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity.
Poo, M.M.
. Neurotrophins as synaptic modulators.
Nat. Rev. Neurosci.
Rose, C.R., R. Blum, B. Pichler, A. Lepier, K.W. Kafitz, and A. Konnerth.
. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells.
Rubio, N.
. Mouse astrocytes store and deliver brain-derived neurotrophic factor using the non-catalytic gp95trkB receptor.
Eur. J. Neurosci.
Santi, S., S. Cappello, M. Riccio, M. Bergami, G. Aicardi, U. Schenk, M. Matteoli, and M. Canossa.
. Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance.
Soldati, T., and M. Schliwa.
. Powering membrane traffic in endocytosis and recycling.
Nat. Rev. Mol. Cell Biol.
Teng, H.K., K.K. Teng, R. Lee, S. Wright, S. Tevar, R.D. Almeida, P. Kermani, R. Torkin, Z.Y. Chen, F.S. Lee, et al.
. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.
J. Neurosci.
Thompson, N.L., and B.L. Steele.
. Total internal reflection with fluorescence correlation spectroscopy.
Nat. Protoc.
Wigge, P., and H.T. McMahon.
. The amphiphysin family of proteins and their role in endocytosis at the synapse.
Trends Neurosci.

Supplementary data